This new specific ROIMB has been designed to quantify fluorescence staining in sarcolemmal or subsarcolemmal regions, such as the dystrophin-glycoproteins complex, where mutations in the genes encoding for its components can cause several muscular dystrophies. The gene discussed is DMD; the disease is muscular dystrophy.